Predictive Technology Group, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020
February 16, 2021 at 04:36 pm EST
Share
Predictive Technology Group, Inc. announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was USD 4.067 million compared to USD 7.336 million a year ago. Operating loss was USD 6.852 million compared to USD 13.727 million a year ago. Net loss was USD 7.104 million compared to USD 26.002 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.09 a year ago. For the half year, sales was USD 9.158 million compared to USD 15.595 million a year ago. Operating loss was USD 21.416 million compared to USD 26.619 million a year ago. Net loss was USD 22.564 million compared to USD 33.867 million a year ago. Basic loss per share from continuing operations was USD 0.08 compared to USD 0.12 a year ago.
Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the bodyâs natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Whartonâs Jelly umbilical cord-derived products to new heights.
PREDICTIVE TECHNOLOGY GROUP, INC. 
